← Back to Search

Surfactant Dressing

WSD for Partial Thickness Burns (EARLY Trial)

N/A
Waitlist Available
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
partial-thickness burn wounds on at least two non-contiguous areas of < 10% TBSA each and not involving face, fingers, toes, and perineum
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 28 days
Awards & highlights

EARLY Trial Summary

This trial is testing whether using a water-soluble surfactant dressing on partial-thickness burn wounds early on will result in less need for surgery, faster healing, less pain, less infection, and lower hospital costs.

Eligible Conditions
  • Partial Thickness Burns
  • Burns

EARLY Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have burns that are not too deep and cover at least two separate areas of your body that are each smaller than 10% of your total body surface area. The burns do not involve your face, fingers, toes, or genital area.

EARLY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent difference (cm2) in partial-thickness wound conversion
Secondary outcome measures
Daily pain scores for each wound care session
Hospital costs
Incidence of burn wound infection and cellulitis
+1 more

EARLY Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Dressed with WSD and petrolatum gauze
Group II: ControlActive Control1 Intervention
Dressed with bacitracin and petrolatum gauze
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
WSD
2021
N/A
~30

Find a Location

Who is running the clinical trial?

University of TennesseeLead Sponsor
188 Previous Clinical Trials
141,614 Total Patients Enrolled
Medline IndustriesIndustry Sponsor
45 Previous Clinical Trials
23,014 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available in the trial for potential participants?

"Affirmative. The details available on clinicaltrials.gov indicate that the research, which was published on August 3rd 2021, is enrolling participants now. 27 people are needed to be recruited from a single medical site."

Answered by AI

How many participants are being welcomed into this research endeavor?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial, which was first announced on August 3rd 2021, is currently recruiting participants. The medical research necessitates the recruitment of 27 patients from a single site."

Answered by AI
Recent research and studies
~8 spots leftby Mar 2025